141 related articles for article (PubMed ID: 26966361)
21. The significance of treating somatic symptoms on functional outcome improvement in patients with major depressive disorder: a post hoc analysis of 2 trials.
Wise TN; Meyers AL; Desaiah D; Mallinckrodt CH; Robinson MJ; Kajdasz DK
Prim Care Companion J Clin Psychiatry; 2008; 10(4):270-5. PubMed ID: 18787676
[TBL] [Abstract][Full Text] [Related]
22. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studies.
Mancini M; Sheehan DV; Demyttenaere K; Amore M; Deberdt W; Quail D; Sagman D
Int Clin Psychopharmacol; 2012 Nov; 27(6):298-309. PubMed ID: 22954893
[TBL] [Abstract][Full Text] [Related]
24. Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study.
Hellerstein DJ; Hunnicutt-Ferguson K; Stewart JW; McGrath PJ; Keller S; Peterson BS; Chen Y
J Affect Disord; 2017 Mar; 210():258-264. PubMed ID: 28064115
[TBL] [Abstract][Full Text] [Related]
25. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine.
Robinson MJ; Sheehan D; Gaynor PJ; Marangell LB; Tanaka Y; Lipsius S; Ohara F; Namiki C
Int Clin Psychopharmacol; 2013 Nov; 28(6):330-8. PubMed ID: 23873291
[TBL] [Abstract][Full Text] [Related]
26. The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms.
Sugawara N; Yasui-Furukori N; Tsuji T; Hayashi S; Ajisawa Y; Ochiai T; Imagawa H; Shimoda K
Neuropsychiatr Dis Treat; 2020; 16():3063-3070. PubMed ID: 33335397
[TBL] [Abstract][Full Text] [Related]
27. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
28. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
29. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
30. Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?
Novick D; Montgomery W; Kadziola Z; Moneta V; Peng X; Brugnoli R; Haro JM
Patient Prefer Adherence; 2013; 7():463-70. PubMed ID: 23818764
[TBL] [Abstract][Full Text] [Related]
31. Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.
Oakes TM; Myers AL; Marangell LB; Ahl J; Prakash A; Thase ME; Kornstein SG
Hum Psychopharmacol; 2012 Jan; 27(1):47-56. PubMed ID: 22241678
[TBL] [Abstract][Full Text] [Related]
32. Impact of pain and remission in the functioning of patients with depression in Mainland China, Taiwan, and Hong Kong.
Novick D; Shi Q; Yue L; Moneta MV; Siddi S; Haro JM
Asia Pac Psychiatry; 2018 Jun; 10(2):e12295. PubMed ID: 28960863
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
34. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
Demyttenaere K; Desaiah D; Petit C; Croenlein J; Brecht S
Curr Med Res Opin; 2012 Jan; 28(1):41-8. PubMed ID: 22126422
[TBL] [Abstract][Full Text] [Related]
35. Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study.
Harada E; Satoi Y; Kuga A; Tokuoka H; Kikuchi T; Watanabe K; Alev L; Mimura M
Neuropsychiatr Dis Treat; 2017; 13():2437-2445. PubMed ID: 29033569
[TBL] [Abstract][Full Text] [Related]
36. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
[TBL] [Abstract][Full Text] [Related]
37. Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics.
Perahia DG; Kajdasz DK; Royer MG; Walker DJ; Raskin J
Int Clin Psychopharmacol; 2006 Sep; 21(5):285-95. PubMed ID: 16877900
[TBL] [Abstract][Full Text] [Related]
38. Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies.
Brnabic A; Lin C; Monkul ES; Dueñas H; Raskin J
Curr Med Res Opin; 2012 Dec; 28(12):1891-7. PubMed ID: 23145858
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine in the long-term treatment of major depressive disorder.
Raskin J; Goldstein DJ; Mallinckrodt CH; Ferguson MB
J Clin Psychiatry; 2003 Oct; 64(10):1237-44. PubMed ID: 14658974
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
Goldstein DJ; Lu Y; Detke MJ; Wiltse C; Mallinckrodt C; Demitrack MA
J Clin Psychopharmacol; 2004 Aug; 24(4):389-99. PubMed ID: 15232330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
